Christie Hospital NHS Trust, Manchester
Studies add new findings to pancreatic cancer body of knowledge
Published in Lab Law Weekly, March 31st, 2006
Study 1: Weekly cisplatin and gemcitabine could be used to treat patients with pancreatic cancer.
"A phase II study [was conducted] to assess the activity of the cisplatin gemcitabine combination in patients with advanced pancreatic cancer. Chemotherapy-naive patients with locally advanced/metastatic/relapsed adenocarcinoma of the pancreas received cisplatin 25 mg/m2 followed by gemcitabine 1000 mg/m2 intravenously on days 1, 8, and 15 of a 28-day cycle. Radiologic response was assessed after 3 cycles, and treatment continued for up to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2006-03-31)
More Articles from Lab Law Weekly
- Blackwell Publishing Ltd.
Symposium focuses on defining the beginning and end of life - Cel-Sci Corp.
Cel-Sci gets U.S. patent for use of L.E.A.P.S. vaccine technology - Environmental Health
Elderly have higher risk for cardiovascular, respiratory disease from fine particle pollution - Memory Pharmaceuticals Corp.
Memory Pharmaceuticals amends agreement with Roche, expanding nicotinic alpha-7 agonists resources - Research & Markets, Ltd.
Growth of Indian pharmas, effect of patent law and tax policy change discussed in reported - U.S. Food & Drug Administration
U.S. FDA requests seizure of more dietary supplements containing ephedrine alkaloids - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
